Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats

Tian-yang Liu; Ling-ling Zhou; Cong Zhou; Zhang-pu Liu; Chen Chen; Zhe Feng; Xue-ping Zhou

doi:10.1007/s11655-014-1839-x

Your Location：

Home >

Browse articles >

Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats

OriginalPaper | Updated：2021-08-27

- Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats
- Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats
- 中国结合医学杂志（英文版） 2015年21卷第4期页码：291-298
- Affiliations：
  
  1. Nanjing University of Chinese Medicine,Nanjing,China
  2. Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 81072749), the Ministry of Education of Overseas Returnees Research Fund (No. 2006331), Six Talent Peaks Subject of Jiangsu Province (No. 2007), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 20116), Jiangsu Province Ordinary University Innovative Research Project and Ordinary University Innovative Research Project of Jiangsu Province (No. 2011)
- DOI：10.1007/s11655-014-1839-x
  中图分类号：
- 纸质出版日期：2015，
  
  网络出版日期：2014-9-2，
Scan for full text
Liu, Ty., Zhou, Ll., Zhou, C. et al. Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats., Chin. J. Integr. Med. 21, 291–298 (2015). https://doi.org/10.1007/s11655-014-1839-x

Tian-yang Liu, Ling-ling Zhou, Cong Zhou, et al. Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats[J]. Chinese Journal of Integrative Medicine, 2015,21(4):291-298.
Liu, Ty., Zhou, Ll., Zhou, C. et al. Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats., Chin. J. Integr. Med. 21, 291–298 (2015). https://doi.org/10.1007/s11655-014-1839-x DOI：

Tian-yang Liu, Ling-ling Zhou, Cong Zhou, et al. Inhibition mechanism of Qingluo Tongbi Granule (清络通痹颗粒) on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats[J]. Chinese Journal of Integrative Medicine, 2015,21(4):291-298. DOI： 10.1007/s11655-014-1839-x.

摘要

To study the mechanism underlying the inhibitory effect of Qingluo Tongbi Granule (清络通痹颗粒

QTG) on osteoclast differentiation in rheumatoid arthritis in rats. Fibroblast and monocyte co-culture were used to induce osteoclast differentiation in adjuvant-induced arthritic (AIA) rats. Serum containing QTG was prepared and added to the osteoclasts

and activation of the tumor necrosis factor receptor-associated factor 6/mitogen-activated protein kinase/nuclear factor of activated T cells

cytoplasmic1 (TRAF6/MAPK/NFATc1) pathways was examined. The induced osteoclasts were multinucleated and stained positive for tartrate-resistant acid phosphatase (TRAP) staining. Serum containing QTG at 14.4

7.2 or 3.6 g/kg inhibited the activation of TRAF6

extracellular regulated protein kinase (ERK)1/2

c-Jun N-terminal kinase (JNK) and p38 and decreased the percentage of cells with nuclear NFATc1 in a dose-dependent manner

the high and middle doses exhibited clear inhibitory activity (P<0.01 and P<0.05

respectively). After the addition of MAPK inhibitors

the NFATc1 expression showed no significant difference compared with the control group (P>0.05). Serum containing QTG could generally inhibit the TRAF6/MAPK pathways and possibly inhibit the NFATc1 pathway. In addition

QTG may regulate other signaling pathways that are related to osteoclast differentiation and maturation.

Abstract

To study the mechanism underlying the inhibitory effect of Qingluo Tongbi Granule (清络通痹颗粒

and activation of the tumor necrosis factor receptor-associated factor 6/mitogen-activated protein kinase/nuclear factor of activated T cells

7.2 or 3.6 g/kg inhibited the activation of TRAF6

extracellular regulated protein kinase (ERK)1/2

c-Jun N-terminal kinase (JNK) and p38 and decreased the percentage of cells with nuclear NFATc1 in a dose-dependent manner

the high and middle doses exhibited clear inhibitory activity (P<0.01 and P<0.05

respectively). After the addition of MAPK inhibitors

QTG may regulate other signaling pathways that are related to osteoclast differentiation and maturation.

关键词

Qingluo Tongbi Granulerheumatoid arthritisosteoclast differentiationsignaling pathwayregulation of tumor necrosis factor receptor-associated factor 6/mitogen-activated protein kinase pathwaysChinese Medicine

Keywords

references

Dong Y. Rheumatoid arthritis. In: Ye RG, Zhong NS, eds. Internal medicine. Beijing: People’s Medical Publishing House; 2008:712–718.

Lu CJ, Xiang Y, Xie XL, Xuan ML, He ZH. A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula. Chin J Integr Med 2012;18:186–191.

Liu C, Walter, TSH P, Zhang S, Zhu X, Wu Y, et al. Structural and functional insights of RANKL-RANK interaction and signaling. J Immunol 2010;184:6910–6919.

Park MK, Her YM, Cho ML, Oh HJ, Park EM, Kwok SK. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. Immunol Lett 2011;139:42–51.

Trouvin AP, Goëb V. Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clin Interv Aging 2011;19:345–354.

Yavropoulou MP, Yovos JG. Osteoclastogenesis—current knowledge and future perspectives. J Musculoskelet Neuronal Interact 2008;8:204–216.

Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-alpha (TNFα) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. Biol Chem 2001;276:563–568.

Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, et al. Osteoclast differentiation independent of the TRANCERANK-TRAF6 axis. Exp Med 2005;202:589–595.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002;3:889–901.

Boyce BF, Yao Z, Xing L. Functions of nuclear factor kappa B in bone. Ann N Y Acad Sci 2009;1192:367–375.

Xing L, Xiu Y, Boyce BF. Osteoclast fusion and regulation by RANKL-dependent and independent factors. World J Orthop 2012;12:212–222.

Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrionlogy 1996;137:4058–4060.

Chen BS, Xu YD, Zhong SQ. Establishment and evaluation of experimental animal model of CFA induced adjuvant arthritis in rats. J Harbin Med Univ (Chin) 2009;39:489–491.

Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood monnuclear cell cultures. Biochem Biophy Res Commun 1998;246:199–204.

Taira H, Fujikawa Y, Kudo O, Itonaga I, Torisu T. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors. Calcif Tissue Int 2003;73:78–85.

Huang Y, Zhou XP, Wang MY, Zhou LL, Yang YH, Shen JR, et al. Effects of Qingluo Tongbi Granule on proliferation of fibroblast-like synoviocytes and RANKL expression in rheumatoid arthritis patients. Tradit Chin Drug Res Clin Pharmacol (Chin) 2009;20:510–512.

Zhou XP, Zhou LL, Jia M, Wang MY, Lu Y. Effects of Qingluo Tongbi Granule on RANKLE expression in T lymphocytes from RA patients. Chin J Immunol (Chin) 2008;24:1088–1099.

Zhou XP, Zhou LL, Song YH. The effects of Qingluo Tongbi Granule on the levels of cytokines in adjuvant induced arthritis rats. Chin J Immunol (Chin) 2003;19:545–547.

Zhou XP, Zhou LL, Liang W, Wang MY, Jiang HY, Fang TH. Effects of Qingluo Tongbi Granule on T lymphocyte subsets and TNF-α together IL-1 in synoviocytes of collagen induced arthritis in rats. Chin J New Drug Clin Remed (Chin) 2006;25:492–496.

Zhou XP, Fang TH, Zhou LL, Wang MY, Song YH, Xu DQ. Research of the molecular mechanisms of Qingluotongbi granule on rheumatoid arthritis. Pharmacol Clin Chin Mater Med (Chin) 2003;1:35–37.

Han Y, Wang YP, Zhou LL. Effect of Qingluo Tongbi Granules on bone destruction in rats with adjuvant-induced arthritis (AIA). China Pharm (Chin) 2007;36:814–816.

Chen CH, Fang TH, Zhou LL, Zhou XP. Effect of Qingluo Tongbi Granule-containing serum on osteoblasts and osteoclast. Chin Tradit Patent Med (Chin) 2008;30:35–38.

Zhou XP, Liang W, Zhou LL, Wang MY, Liang T. The effects of Qingluo Tongbi Granule on the expression of p53 and bcl-2 mRNA in synoviocyte of collagen induced arthritis rats. Chin J Immunol (Chin) 2006;22:718–720.

Feng ZH. Cell communication and signal transduction. In: Feng HZ, ed. Medical molecular biology. Beijing: People’s Medical Publishing House; 2007:296–298.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

How does Chinese medicine target cytokine imbalance in rheumatoid arthritis?

A one-year evaluation of radiographic progression in patients with rheumatoid arthritis treated by Qingre Huoxue Decoction (清热活血方)

The potential role of Chinese medicine in ameliorating extra-articular manifestations of rheumatoid arthritis

Clinical observation on methotrexate combined with chinese preparations in treating rheumatoid arthritis patients

Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial